Hecheng Li

机构：Shanghai Jiao Tong University, Ruijin Hospital, Second Affiliated Hospital of Xi'an Jiaotong University · ORCID：0000-0001-8069-6033

发表论文 337 篇 · 总被引 6573 次 · h-index 41

代表论文

• Targeting MondoA–TXNIP restores antitumour immunity in lactic-acid-induced immunosuppressive microenvironment (2025 · Nature Metabolism · 被引 29)
• Circulating tumor DNA as a biomarker for progression and survival in esophageal cancer after neoadjuvant therapy and esophagectomy: a systematic review and meta-analysis (2025 · International Journal of Surgery · 被引 11)
• CARD11 signaling regulates CD8+ T cell tumoricidal function (2025 · Nature Immunology · 被引 10)
• Anastomotic leakage following robot-assisted minimally invasive esophagectomy (RAMIE): which anastomosis should be preferred? (2025 · Surgical Endoscopy · 被引 6)
• Preoperative pembrolizumab (anti-PD-1 antibody) combined with chemoradiotherapy for esophageal squamous cell carcinoma: a phase 1/2 trial (PALACE-2) (2025 · Signal Transduction and Targeted Therapy · 被引 5)
• Single-Port Robotic-Assisted Approach in Thoracic Surgery: A Prospective Real-World Study (2025 · Interdisciplinary CardioVascular and Thoracic Surgery · 被引 4)